A Prospective, Randomized Study of Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal at a Large Tertiary Care Medical Center
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2019
Price : $35 *
At a glance
- Drugs Prothrombin complex concentrate (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- 07 Jun 2019 Status changed from recruiting to completed.
- 03 Apr 2019 Planned End Date changed from 1 Jan 2019 to 31 Jul 2019.
- 03 Apr 2019 Planned primary completion date changed from 31 Dec 2018 to 23 Jul 2019.